Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL

Emerging evidence indicates that chemoresistance is closely related to altered metabolism in cancer. Here, we hypothesized that distinct metabolic gene expression profiling (GEP) signatures might be correlated with outcome and with specific fluorodeoxyglucose positron emission tomography (FDG-PET) r...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzara, Saveria, Travaini, Laura, Botta, Francesca, Granata, Chiara, Motta, Giovanna, Melle, Federica, Fiori, Stefano, Tabanelli, Valentina, Vanazzi, Anna, Ramadan, Safaa, Radice, Tommaso, Raimondi, Sara, Lo Presti, Giuliana, Ferrari, Mahila E., Jereczek-Fossa, Barbara Alicja, Tarella, Corrado, Ceci, Francesco, Pileri, Stefano, Derenzini, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979764/
https://www.ncbi.nlm.nih.gov/pubmed/36806558
http://dx.doi.org/10.1182/bloodadvances.2022007825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979764/
https://www.ncbi.nlm.nih.gov/pubmed/36806558
http://dx.doi.org/10.1182/bloodadvances.2022007825

Ejemplares similares